Chagas disease

Urban transmission of Chagas disease in Cochabamba, Bolivia

Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection

A potent trypanocidal component from the fungus Lentinus strigosus inhibits trypanothione reductase and modulates PBMC proliferation

Chromosome variability in the Chagas disease vector Rhodnius pallescens (Hemiptera, Reduviidae, Rhodniini)

Current status and perspectives of cell therapy in Chagas disease

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies

Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true

Chagas disease, adipose tissue and the metabolic syndrome

Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease

Do Archaea and bacteria co-infection have a role in the pathogenesis of chronic chagasic cardiopathy?

Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research

All-around care for patients with Chagas disease: a challenge for the XXI century

Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina

Morbidity and prognostic factors in chronic chagasic cardiopathy

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

Viability study of a multiplex diagnostic platform for Chagas disease

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

Trypanosoma cruzi: ancestral genomes and population structure

Sylvatic triatominae: a new challenge in vector control transmission

Exploiting triatomine behaviour: alternative perspectives for their control

Wild Triatoma infestans, a potential threat that needs to be monitored

Biology, diversity and strategies for the monitoring and control of triatomines - Chagas disease vectors

Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery

Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy

Paleoparasitology of Chagas disease: a review

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

Gap junction reduction in cardiomyocytes following transforming growth factor-β treatment and Trypanosoma cruzi infection

Morphological study of the eggs and nymphs of Triatoma dimidiata (Latreille, 1811) observed by light and scanning electron microscopy (Hemiptera: Reduviidae: Triatominae)

A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras

In vitro activity of thienyl-2-nitropropene compounds against Trypanosoma cruzi

Serological diagnosis of Chagas disease: evaluation and characterisation of a low cost antigen with high sensitivity and specificity

Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples

Epidermal growth factor receptors, testosterone levels and parotid gland changes in rats infected with Trypanosoma cruzi

Susceptibility of Triatoma infestans to deltamethrin in Rio Grande do Sul, Brazil

Present situation and new strategies for Chagas disease chemotherapy: a proposal

Response of Triatoma infestans to pour-on cypermethrin applied to chickens under laboratory conditions

Reassessing the entomological investigation around the first autochthonous case of Chagas disease in Western Brazilian Amazon

Immunological imbalance between IFN-³ and IL-10 levels in the sera of patients with the cardiac form of Chagas disease

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up

Attraction of Chagas disease vectors (Triatominae) to artificial light sources in the canopy of primary Amazon rainforest

The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease

Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study

Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases

Residual effect of a micro-encapsulated formulation of organophosphates and piriproxifen on the mortality of deltamethrin resistant Triatoma infestans populations in rural houses of the Bolivian Chaco region

The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice

Absence of domestic triatomine colonies in an area of the coastal region of Ecuador where Chagas disease is endemic

Inscrever-se em Chagas disease